Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study.
about
State of the Art: Newer biomarkers in heart failureAhR expression and polymorphisms are associated with risk of coronary arterial disease in Chinese populationA Sensitive Cardiac Troponin T Assay in Stable Coronary Artery DiseaseMyocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study.Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study.Cardiomyocyte injury assessed by a highly sensitive troponin assay and sudden cardiac death in the community: the Cardiovascular Health Study.Subclinical myocardial necrosis and cardiovascular risk in stable patients undergoing elective cardiac evaluation.Circulating microRNA-19a as a potential novel biomarker for diagnosis of acute myocardial infarctionClinical and biochemical prediction of early fatal outcome following hip fracture in the elderly.Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease.Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study.Myocardial infarction in the elderlyClinical utility of novel biomarkers in the prediction of coronary heart disease.Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy.Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).Running on empty: cardiovascular reserve capacity and late effects of therapy in cancer survivorship."Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes.Identification of myocardial injury in the emergency setting.Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population.Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms?High-sensitivity troponin assay improves prediction of cardiovascular risk in patients with cerebral ischaemia.Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: an observational studyMinimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.New and emerging risk factors for CVD.Troponin revisited 2008: assay performance.Biomarkers of atherosclerosis: clinical applicationsHomocysteine is associated with plasma high-sensitivity cardiac troponin T levels in a community-dwelling population.Cardiovascular biomarkers and their utility in the older adult.From circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population.Towards appreciating appropriate clinical responses to highly sensitive cardiac troponin assays.Biomarkers in atrial fibrillation: a clinical review.Cardiac troponin level elevations not related to acute coronary syndromes.Biomarkers in atrial fibrillation: an overview.Making sense of high sensitivity troponin assays and their role in clinical care.High-Sensitivity Cardiac Troponin for the Diagnosis of Patients with Acute Coronary Syndromes.Novel biomarkers for cardiovascular risk assessment: current status and future directions.High-Sensitivity Cardiac Troponin I Is a Strong Predictor of Cardiovascular Events and Mortality in the AGES-Reykjavik Community-Based Cohort of Older Individuals.A window into your heart: taking cardiac troponin to the next level.Higher prevalence of detectable troponin I among cocaine-users without known cardiovascular disease.
P2860
Q27027899-D92EDC26-BB23-41B2-BA8B-FD3275011FA7Q28386512-92871254-793A-4FA8-97FB-C46481731B54Q29028464-BF2955C1-CD61-4232-A966-650CFD4EAB7FQ30426457-C5D9C253-23EA-4E90-A1AA-E367A15EE7C4Q33506787-A090E530-1E60-4911-8A51-F5BC70224B16Q34150309-34B76218-2E14-4697-A1A0-DE194C002568Q34610511-C1BEADFA-5B0A-4C38-BA45-9671A1F4B830Q34685379-6586EFD5-03B7-4FF8-A03E-3946C50B971EQ35013126-29767403-DBD3-4137-BB29-52DBC46A4339Q35071384-6839238B-F604-4FDC-B0FD-487B0C20E5A3Q35130613-CFEF126A-B081-4EA8-BD3F-412A85AA9E8AQ35806730-0B97FE79-E28E-4208-A920-27BD390A2AACQ35925691-8166E569-8A53-4DE3-8EDD-A6FBF23B1D73Q36332458-30098413-9BAF-495B-A2EA-FEDFA903FA87Q36385601-1FF54D41-A410-4CD5-B800-7A76EA9641D2Q36457166-04719954-CBD4-481C-95D7-06E6ABFEB8E9Q36601665-FF7AEEBE-D17A-42E2-B648-76C4BB5AC81EQ36601679-B6511977-F0AD-443E-87E6-9C0818045AD0Q36601689-E1EC7B9F-C636-4775-B40D-A1615E27627EQ36601701-FCE4208F-B4E8-4725-BE05-5F41483185B2Q36756920-F53E5171-64A8-4193-9A6A-2D62CF2C8E54Q36828022-22A76181-AF6C-4A03-ADB9-4E1F72546C70Q37036751-266D6E3D-5612-4CDB-A055-6F5A6E6A3F31Q37041666-C0D93B32-CBC4-46EC-AE2C-7774A5797761Q37138669-A36F5F1A-4FEA-4C18-81A9-435C029E8E53Q37289429-6253525F-753F-471E-AF10-41F25F49899EQ37307999-DE2447F2-7742-472D-A228-B67CB7C2A822Q37444674-10D2BA47-A985-4725-9C80-45A007F647C0Q37691417-A864B9BF-C3FA-4DBC-9575-374DC2D02881Q37881966-0F202EA1-78BF-4C9F-BF58-0606AC2A6A67Q38049324-6E5589E7-146A-4955-9062-08ADCE5CBE79Q38079565-7939F888-38F7-4F54-B527-5C6965A821F8Q38131688-CF084B01-B13E-486B-B4C8-DF4F9CB35AE9Q38174213-C5C85932-A64C-42D2-8565-ACCEC77C2D17Q38192517-9C5A855B-0F82-4CDB-B4D0-22EB4B3A43F6Q38608703-00FEF5E9-0E5C-47DE-A1E0-705746B8B28DQ38613760-A5BBB557-D3C3-4113-8513-DDF4E4944E1EQ38900727-F4957E1B-47DD-47EA-B4F3-D6D771B02DB0Q39809276-D0476CD5-1225-48A3-AB4E-3D5DDBDABA6DQ40347012-FE3F1D32-546D-4C58-8DA1-602DC7A26DDE
P2860
Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Troponin I as a predictor of c ...... community-based cohort study.
@ast
Troponin I as a predictor of c ...... community-based cohort study.
@en
Troponin I as a predictor of c ...... community-based cohort study.
@nl
type
label
Troponin I as a predictor of c ...... community-based cohort study.
@ast
Troponin I as a predictor of c ...... community-based cohort study.
@en
Troponin I as a predictor of c ...... community-based cohort study.
@nl
prefLabel
Troponin I as a predictor of c ...... community-based cohort study.
@ast
Troponin I as a predictor of c ...... community-based cohort study.
@en
Troponin I as a predictor of c ...... community-based cohort study.
@nl
P1433
P1476
Troponin I as a predictor of c ...... community-based cohort study.
@en
P2093
Nina Johnston
P304
P356
10.1161/CIRCULATIONAHA.105.570762
P407
P577
2006-02-20T00:00:00Z